Acupuncture/Moxibustion (Acu/Moxa) for Distal Symmetric Peripheral Neuropathy (DSP) in HIV

Inclusion Criteria: * Men and women HIV positive or CDC defined AIDS diagnosed subjects who are 18 years of age or older, have a history of distal symmetrical peripheral neuropathy of the lower extremities (legs and feet) for two months or greater. * Experiencing patient rated pain severity at "moderate" on the Gracely pain scale documented in 1 week prospective self report symptom diary. * Verification from Primary provider of subject's: HIV status, diagnosis of DSP, and their agreement that their patient is clinically suitable for the study. * Individuals able to successfully complete a mini-mental status exam (obtaining a score of 24 or above). * Individuals who understand and agree to complete daily symptom diaries for the duration of the study. * Individuals taking antiretroviral combinations (a) must have completed an initial 8 weeks of a stable regime (same drug(s), dose \& frequency) prior to entry into the study. * Individuals taking chronic pain medications (b) must be on a stable regime (same drug, dose \& frequency) for at least twenty one (21) days prior to entry into the study. * Individuals on all other medications which may have neuropathy listed as a side effect must be on a stable regime (same drug(s), dose \& frequency) for at least 21 days prior to entry in the study. Exclusion Criteria: * Individuals with an acute medical condition, i.e. pneumocystis carinii pneumonia, tuberculosis and or other opportunistic infections or conditions that would require medical attention. * Individuals with diagnosis of diabetes mellitus, B12 deficiency * Topically applied medications to the lower extremities. * Individuals with alcohol and/or substance dependence. * Individuals with bleeding tendency * Currently receiving treatment with corticosteroids * Use of INH, dapsone or metronidazole within 8 weeks prior to enrollment.